← Human Trials & Peer-Reviewed Studies
The impact of oral carbohydrate-rich supplement taken two hours before caesarean delivery on maternal and neonatal perioperative outcomes -- a randomized clinical trial.
Plain-language guide to PMID 34620123 (2021): randomized controlled trial of Copper (Supplement).
Key Facts
- PMID
- 34620123
- Journal
- BMC pregnancy and childbirth
- Year
- 2021
- Study type
- Randomized Controlled Trial
- Authors
- He Y et al. (6 authors)
- DOI
- 10.1186/s12884-021-04155-z
What This Study Did, in Plain Language
What Was Tested
The paper reports a study of Copper (Supplement), published as a randomized controlled trial.
To evaluate the impact of oral carbohydrate-rich (Ch-R) supplement taken 2 hours before an elective caesarean delivery (CD) on maternal and neonatal perioperative outcomes.
Why It Was Studied
Chinese Clinical Trial Registry, ChiCTR2000033163.
Who Took Part
PubMed indexes the participants as adults, both men and women.
Ninety pregnant women undergoing elective CD were randomized into the Ch-R group, placebo group and fasting group equally.
Participants' blood was drawn at three time points, before intervention, immediately after and 1 day after the surgery to measure maternal and neonatal biochemical indices.
How the Study Was Run
The researchers set it up as a randomized and placebo-controlled study.
Random assignment meant chance, not the researchers, decided who got Copper (Supplement) and who got the comparison, which limits bias.
The comparison arm used a placebo, so changes seen with Copper (Supplement) could be set against what happens without it.
Meanwhile women's perioperative symptoms and signs were recorded.
What Was Measured
Topics PubMed links to this paper include Blood Glucose, Cesarean Section, Dietary Carbohydrates, Dietary Supplements, Enhanced Recovery After Surgery, Homeostasis and Insulin.
Author keywords: Caesarean delivery (CD), Enhanced recovery after surgery (ERAS), Homeostatic model assessment of insulin resistance (HOMA-IR), Neonatal glucose level and Oral carbohydrate-rich supplement.
What This Means in Plain Language
The paper is a randomized and placebo-controlled study of Copper (Supplement).
Results are reported in around 5 sentences of the abstract; we leave them to the paper itself rather than summarise them.
The publication is from 2021 (BMC pregnancy and childbirth), a journal based in England.
More context: the Copper (Supplement) compound page, all human trials.
Our Notes on the Compound
Copper (Supplement): The active site of cytochrome c oxidase is described as containing copper ions that are essential for electron transfer.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.